Advarra Acquires YourEncore
Advarra has announced the acquisition of YourEncore.
“We’re excited that YourEncore is becoming part of Advarra,” said Gadi Saarony, CEO of Advarra. Together, they will aim to progress a shared vision of accelerating the drug development lifecycle and the delivery of therapies to patients.
Advarra’s consulting services currently assist biopharmaceutical companies, device manufacturers, academic medical centers, health systems, and institutions in nearly 60 countries. “The addition of YourEncore is a huge step forward for Advarra’s consulting services business, building on and broadening our existing team and solutions across the clinical research spectrum,” said Scott Uebele, President and Chief Research Services Officer of Advarra.
For more information, click here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
